Neogen Chemicals Schedules Q3 FY26 Earnings Conference Call for Feb 12
Neogen Chemicals Limited will host an earnings conference call on February 12, 2026, at 2:00 PM IST to discuss Q3 FY26 results. The company, a key manufacturer of specialty chemicals, is also progressing on battery material projects in Dahej, Gujarat, expected to commence operations in 2026.
This is a routine announcement regarding a conference call for discussing financial results. It does not involve any immediate material changes to the company's operations, financials, or strategic direction.
The announcement is a standard intimation of a conference call to discuss financial results. It does not contain any new financial data or significant business updates that would strongly influence sentiment.
Neogen Chemicals Limited has announced the schedule for its earnings conference call to discuss the results for the quarter and nine months ended December 31, 2025. The call is set to take place on Thursday, February 12, 2026, at 2:00 PM IST.
The conference call will feature a management discussion on the Q3 FY26 results, followed by a question and answer session with senior members of the management team. Participants are encouraged to pre-register via a provided link to receive dial-in numbers, passcode, and a PIN via email, enabling a smoother connection.
Neogen Chemicals Limited, a leading manufacturer of Bromine-based and Lithium-based specialty chemicals, serves various industries including pharmaceuticals and agrochemicals. The company operates four manufacturing facilities and has expanded its product portfolio to over 258 products. It also engages in custom synthesis and contract manufacturing. Recent developments include the merger of Buli Chemicals India Private Limited and land acquisition in Dahej, Gujarat, for battery materials projects, with construction progressing significantly for a 2026 operational start.
What to do with a filing like this
Neogen Chemicals Limited filed this with the NSE as a statutory disclosure, categorised under concall scheduled. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Neogen Chemicals Limited. Read the original for the full detail.